This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Roflumilast

Daxas - Roflumilast - AstraZeneca UK Ltd

Roflumilast is a phosphodiesterase type-4 inhibitor with anti-inflammatory properties.

• Adult: 250 mcg once daily for 28 days, then 500 mcg once daily for maintenance.

Roflumilast - Alliance Healthcare

Roflumilast is a phosphodiesterase type-4 inhibitor with anti-inflammatory properties.

• Adult: 250 mcg once daily for 28 days, then 500 mcg once daily for maintenance.

Roflumilast - Milpharm

Roflumilast is a phosphodiesterase type-4 inhibitor with anti-inflammatory properties.

• Adult: 250 mcg once daily for 28 days, then 500 mcg once daily for maintenance.